In recent studies, BCL6B has been identified as a novel tumour suppressor, which is silenced or downregulated by promoter hypermethylation and is associated with poor survival in colorectal carcinoma [15], hepatocellular carcinoma [16, 17] and GC [18–20]. The gene discussed is BCL6B; the disease is neoplasm.